Occipital Neuralgia Responding to Palmitoylethanolamide

Headache

Volumn 57, Issue 10, 2017, Pages E23-E24

  Calabrò, Rocco Salvatore ^a   Bramanti, Placido ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

neuropathic pain; occipital neuralgia; palmitoylethanolamide

Indexed keywords

GABAPENTIN; PALMIDROL;

ADULT; ALLODYNIA; BURNING SENSATION; CASE REPORT; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG RESPONSE; DRUG WITHDRAWAL; DYSESTHESIA; FEMALE; HUMAN; HYPERALGESIA; IDIOPATHIC DISEASE; LETTER; NEURALGIA; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

EID: 84878022206     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12136     Document Type: Letter

References (5)

1. Vanelderen P, Lataster A, Levy R, Mekhail N, van Kleef M, Van Zundert J. Occipital neuralgia. Pain Pract. 2010;10:137-144.
2. Hesselink JM, Hekker TA. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: A case series. J Pain Res. 2012;5:437-442.
3. Calabrò RS, Gervasi G, Marino S, Mondo PN, Bramanti P. Misdiagnosed chronic pelvic pain: Pudendal neuralgia responding to a novel use of palmitoylethanolamide. Pain Med. 2010;11:781-784.
4. O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease. Immunobiology. 2010;215:611-616.
5. Aloe L, Leon A, Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions. 1993;39:145-147.